Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV testing news


From To
New South Wales puts 9000 people on PrEP, achieves a one-third decline in new HIV infections

The state of New South Wales in Australia has seen a fall of one-third in diagnoses of recent HIV infection since it started its pre-exposure

15 March 2018
Gus Cairns
High uptake of HIV self-testing by men who have sex with men and transgender women in Burma

HIV self-testing is feasible and acceptable for men who have sex with men (MSM) and transgender women (TGW), engaging more people than usual testing services,

12 March 2018
Roger Pebody
There's an uptick in HIV in these millennial groups. Here's why.

The Centers for Disease Control and Prevention (CDC) just released a report about HIV trends for people under 30 in the U.S., and the numbers show an increase in one particular group: 25- to 29-year-olds. Rates of HIV testing are low among millennials.

27 February 2018
Early HIV diagnosis in infants works in Africa, but the technology must spread to save lives

For infants born with HIV, a rapid introduction to necessary treatment is often the lifeline between whether a child will live or die. The recent introduction of a life-saving, point-of-care diagnostic technology in sub-Saharan Africa could become a global solution to preventing infant deaths from HIV.

23 February 2018
Multi-disease testing offers new ways to streamline disease management, Unitaid report says

Innovators are responding to the world’s growing co-infection crisis by developing devices that can quickly, accurately diagnose multiple diseases at a time. Unitaid’s new landscape report, launched today, profiles more than 95 such devices, already on the market or in development, all of which address at least one of Unitaid’s key disease areas—HIV, hepatitis C (HCV), tuberculosis (TB) and malaria.

02 February 2018
Study finds more than half of patients worldwide don’t access HIV treatment until immune systems are severely compromised

Data from nearly a million patients starting treatment for HIV across the world over the last decade shows 55 percent of them accessed antiretroviral treatment only after their immune cell — or CD4 — counts had dropped below 200, leaving them extremely vulnerable to illnesses and infections.

02 February 2018
Science Speaks
A More Sensitive Saliva-Based HIV Test Is in the Works

Preliminary experiments suggest that the investigatory saliva test can identify HIV earlier in the course of infection compared with currently available spit-based assays. However, this experimental test will not likely identify new HIV infections as early as a blood test can.

25 January 2018
Using social and risk networks helps identify people undiagnosed with HIV

Conducting HIV testing among the social and risk networks of those recently diagnosed with HIV helps identify undiagnosed cases of HIV at significantly higher rates and at a lower cost than other testing approaches, finds a new study conducted in Ukraine by an international research team.

22 January 2018
Eurekalert Inf Dis
Internet-based STI testing nearly doubles uptake vs. clinic visits

Introducing patients to internet-based STI testing services could increase testing uptake compared with traditional face-to-face clinical services, according to study findings.

31 December 2017
New evidence supports HIV screening in young adulthood

Study indicates that age 25 would be better than younger ages for a single HIV screening test among those without symptoms.

20 December 2017
Science Daily
← First12345...105Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.